Respiratory

Type D personality was linked to lower adherence and more side-effects in bilevel positive airway pressure therapy for sleep apnoea patients.

Study finds indoor air pollution peaks in respiratory patients are driven by daily activities like cooking, often exceeding WHO guidelines.

Large study shows reducing dampness through home upgrades improves respiratory health, especially in children, supporting housing as a key public health intervention.

New research explores COVID-19 outcomes in cystic fibrosis transplant recipients, highlighting lung function as a potential factor linked to disease severity.

Survival rates in mice increased from 0% to 62.5%, alongside marked reductions in inflammation, alveolitis, and extracellular matrix deposition.

Severe COVID-19 may raise lung cancer risk by creating a tumour-promoting lung environment after viral pneumonia, new research suggests.

High-frequency oscillatory ventilation (HFOV) reduced bronchopulmonary dysplasia in preterm infants with neonatal respiratory distress.

A new human lung ageing atlas reveals cell-specific changes, mutation buildup, and declining lung repair capacity linked to ageing.

Distinct COPD phenotypes show major differences in severity and mortality, with worse outcomes linked to income, race, rural living, and smoking.

Pipe and cigar smoking is linked to faster lung function decline and higher mortality, even among people who have never smoked cigarettes.

Adhering to Life’s Essential 8 may lower chronic respiratory disease risk and support long-term lung health, reports a large population-based study.

High adherence to the Mediterranean diet was linked to a significantly lower risk of adult-onset asthma in a large Spanish cohort study.

Obstructive sleep apnoea may affect 1 in 5 adults in the UK and USA, costing billions in lost productivity, but can be offset by effective treatment.

Indoor asthma triggers such as smoking, poor ventilation, and mould are strongly linked to worse symptoms and daily limitations, a large study finds.

A European study finds hospitalisations and insufficient growth reduce health-related quality of life in childhood interstitial lung disease.

UCLA researchers use lipid nanoparticles to insert full CFTR gene into airway cells, restoring function and opening new avenues for CF therapy.

Major study finds chronic exposure to wildfire smoke PM2.5 linked to 24,000 USA deaths per year, with no safe threshold and strong neurological impacts.

Lung cancer in never smokers is rising, with distinct risks and biology, highlighting the need for tailored screening, prevention, and treatment.

A new study finds adults consuming more sugary drinks have higher odds of COPD, highlighting links between diet, lung health, and overall wellbeing.

New registry data show bronchiectasis affects multiple alpha-1 antitrypsin deficiency genotypes, not just Pi*ZZ, with key implications for screening.

Global research shows asthma microbiome and airway inflammation differ by region, but neutrophilic asthma shows consistent bacterial patterns.

Residential wood burning contributes substantially to winter PM2.5 pollution in the USA, linked to thousands of premature deaths.

A large meta-analysis identifies patient, clinical, and biochemical factors linked to early mortality in septic shock, helping clinicians stratify risk.

Nationwide cohort data suggest vitamin K antagonists are linked to a lower 1-year risk of severe COPD exacerbation or death compared with DOACs.

Study of over 600,000 people finds genetic differences influencing pneumonia risk across age, immunity, and smoking behaviour.

Large genetic study links telomere-related polygenic risk to distinct idiopathic pulmonary fibrosis subgroups, improving disease prediction.

A major trial finds the beta blocker bisoprolol neither improves nor worsens outcomes in people with COPD, despite their high cardiovascular risk.

UK Biobank study links very low vitamin D levels with higher risk of hospital admission for respiratory tract infections across ethnic groups.

Sphingolipid-to-steroid ratios in blood accurately predict asthma attacks years in advance, offering a new precision medicine tool for asthma care.

Teens with obesity using GLP-1RAs experienced fewer asthma exacerbations, emergency visits, and steroid prescriptions compared with nonpharmacological weight management.

Expanded school tobacco prevention in California schools was linked to lower adolescent tobacco use in a large, state-representative survey.

High cannabis use is associated with worse lung function, respiratory symptoms, and airway immune changes, highlighting potential clinical risks.

Meta-analysis links prior tuberculosis and chronic bronchitis to higher lung cancer risk in never-smokers, with implications for clinical risk assessment.

Therapist-guided internet CBT safely lowers asthma-related anxiety and boosts quality of life, control, and behaviour in adults with asthma.

A 1000 ng/mL D-dimer threshold safely rules out pulmonary embolism in low-likelihood patients, reducing unnecessary chest imaging in emergency care.

Combining a host biomarker with large language model analysis improves lower respiratory tract infection diagnosis in ICU patients, reducing uncertainty.

NHS opt-out tobacco dependency services boost quit attempts in deprived populations, but success lags, highlighting opportunities to reduce inequalities.

Medication-induced deep sedation in ICU patients is linked to loss of independence; lighter sedation and mobility improve outcomes, study finds.

A novel iPSC-derived lung-on-chip model mimics human alveolar tissue, revealing macrophage-driven tuberculosis responses.

Rare inherited genetic variants linked to mucin glycosylation and DNA repair significantly increase familial lung cancer risk, offering new targets for early detection.

New trial analysis shows COPD treatment withdrawal, including LAMA and ICS discontinuation, can trigger early exacerbation risk.

Sea saline nasal irrigation lowers bacterial colonisation and incidence of acute upper respiratory infections in children.

The nSOFA score predicts prolonged mechanical ventilation in newborns with NRDS. Early risk stratification may improve NICU care and outcomes.

Study shows that exhaled volatile organic compounds, including propanoic and nonanoic acids, could be used as non-invasive biomarkers for asthma.

New meta-analysis finds e-cigarette use may increase the risk of heart attack and stroke, even after adjusting for cigarette smoking.

Chronic bronchitis affects nearly 10% of adults in low- and middle-income countries, with links to worse respiratory outcomes.

New research identifies a specific monocyte gene signature that predicts mortality in IPF, offering potential targets precision medicine.

Gas stoves are a major source of indoor nitrogen dioxide, raising exposure levels WHO guidelines for millions of people.

Combining glecirasib and sitneprotafib shows encouraging efficacy and safety in patients with KRAS G12C-mutated NSCLC.

Over half of patients with severe asthma discontinued oral corticosteroids while maintaining disease control, major study finds.

Depression and anxiety increase asthma attack risk in adults, highlighting need for targeted care in those with comorbid mental health disorders.

Women show larger improvements in symptoms and wellbeing after lung volume reduction, despite similar physical changes to men.

A new score based on the 6-minute walk test helps predict serious outcomes in lung disease by combining symptoms, oxygen use, distance and oxygen levels.

Although genetic analysis shows little direct link between chronic respiratory and cardiovascular diseases, shared factors like smoking and inflammation drive risk in both conditions.

Maternal use of inhaled corticosteroids during pregnancy improves early lung function in infants born to asthmatic mothers. This intervention may reduce early respiratory risk.

New research reveals that abnormal chest X-ray results strongly predict future TB risk, emphasising the value of early screening.

A European survey of 470 clinicians shows major differences in how LAMAs are prescribed for severe asthma.

Fixed airway obstruction in severe asthma shows distinct clinical and biological traits, with some patients improving over time.

A 15-year study finds COPD patients with chronic respiratory failure face higher and earlier risks of heart disease, demonstrating the need for targeted screening.

Never-smokers with severe α1-antitrypsin deficiency can still develop lung disease, including emphysema, bronchiectasis, and airflow obstruction.

Study shows cigarette prices and age-of-sale laws impact youth smoking in the EU, with effects varying by region and gender.

Adjunctive low-dose glucocorticoids lower 30-day mortality in adults with community-acquired pneumonia in low-resource hospital settings.

A Swedish study found COVID-19 infection in pregnancy greatly raises preterm birth risk within 2 weeks, especially if unvaccinated. Vaccination offers key protection.

Tezepelumab reduced oral corticosteroid use in patients with severe asthma, with well-controlled asthma rising from 3% to 27% after 1 year.

Real-world study finds anti-IL5 therapy significantly reduces moderate and severe exacerbations in asthma and COPD patients, with major hospitalisation prevention.

Younger adults with early-onset lung cancer face poorer survival linked to late diagnosis, income, and access to care, highlighting urgent equity needs.

A Taiwanese study identifies lncZPBP2-3 as a pollution-responsive gene variant that heightens asthma risk with long-term PM2.5 exposure.

The MUSIC trial shows high-dose fluticasone elevates sputum bacterial load in severe COPD, without affecting upper airway microbiome, and ICS withdrawal can trigger exacerbations.

The ERS has released evidence-based guidelines for adult bronchiectasis care, offering structured recommendations on airway clearance, macrolides, and inhaled antibiotics.

Hypnosis can enhance comfort and clinical efficacy of non-invasive ventilation masks, reducing sedation needs and distress in acute respiratory failure patients.

New Mendelian randomisation study confirms a causal link between gut microbiota and childhood asthma.

A phase 3 trial found that retifanlimab plus chemotherapy significantly improved survival in patients with metastatic NSCLC, with a safety profile consistent with other PD-1 inhibitors.

New ERS 2025 research links paternal smoking in puberty with accelerated biological ageing in offspring, reinforcing evidence of intergenerational tobacco harms.

A multicentre study presented at ERS Congress 2025 found that remote monitoring reduced hospital visits and improved asthma control in children, strengthening the case for digital health in routine asthma care.

New research shows that paternal smoke exposure before puberty is associated with reduced lung function trajectories in offspring, increasing long-term respiratory risk.

A UK Biobank analysis presented at ERS Congress 2025 found that higher fruit intake reduced the negative effects of fine particulate air pollution on lung function, particularly in women.

The CHILD study analysis found that early exposure to higher levels of dog allergen reduced asthma risk and improved lung function at age 5, with effects modified by genetic background.

Robotic-assisted bronchoscopy with cone-beam CT achieved far higher diagnostic yields than conventional bronchoscopy, particularly for small and ground-glass lesions, offering a powerful new tool for early lung cancer diagnosis.

ECPR can restore circulation and tissue oxygenation, substantially improving survival and offering a favourable functional recovery.

A machine learning model combining CT radiomics with clinical data has shown accuracy comparable to experienced pulmonologists in diagnosing usual interstitial pneumonia and predicting survival outcomes.

A randomised trial finds that blowing a conch shell reduces daytime sleepiness, improves sleep quality, and lowers apnoea severity in people with obstructive sleep apnoea.

ERS/EULAR guidelines provide detailed recommendations for diagnosing, monitoring, and treating connective tissue disease-related interstitial lung disease, tailored to disease type and risk profile.

Study finds trained dogs detect lung cancer with 78% accuracy from breath samples versus 42% from saliva.

Hospital asthma exacerbations rise in later pregnancy, with reduced inhaled corticosteroid use a key modifiable risk factor, UK data show.

By 2050, nearly half of US adults aged 30–69 will have obstructive sleep apnoea, with cases rising to 76.6 million and the steepest growth seen in women.

Central tumour location linked to worse survival in lung cancer, suggesting need for closer post-operation monitoring.

Understand how an AI model uses chest CT scans to diagnose COPD with 95% accuracy.

A nearly three-decade study has revealed a significant rise in triazole-resistant Aspergillus fumigatus, a fungus responsible for invasive aspergillosis…

Study shows diets high in saturated fatty acids drive lung inflammation and worsen airway disease, similarly to obesity-related asthma.

Airway bacteria like Streptococcus oralis may boost natural immune defences, helping protect against pneumonia and viral infections, new research suggests.

COVID-19 infection raises risks of asthma, rhinitis, and sinusitis, while vaccination reduces respiratory type-2 inflammatory disease incidence.

Respiratory viruses such as influenza and SARS-CoV-2 can awaken dormant breast cancer cells, driving metastasis and raising mortality risk in cancer survivors, new research finds.

A registry-based analysis using Bayesian modelling has mapped the pathways linking biomarkers, lung function, and comorbidities to severe asthma exacerbation risk.

A UK registry study shows asthma biologics improve outcomes across BMI groups, but obese patients remain more likely to have uncontrolled disease.

A large pooled analysis shows that kidney problems are common in PAH and CTEPH, worsen survival, and see only minor improvement with current pulmonary hypertension therapies.

Meta-analysis confirms low income is linked to increased asthma exacerbations, especially in children, highlighting income inequality as a key risk factor.

A global trial finds a shorter all-oral regimen for pre-XDR tuberculosis fails to match the efficacy of standard care, with poorer results in those with extensive disease.

A new Europe-wide analysis reveals that RSV hospitalisations in older adults are far more common than previously reported, highlighting the importance of updated data in vaccine policy planning.

A new AI model shows promise in predicting survival in patients with fibrotic lung disease, offering more precise prognosis than standard tests and imaging methods.

Real-world study finds benralizumab leads to long-term clinical remission in up to 39% of patients with severe eosinophilic asthma.

Long-term exposure to fine particulate matter and nitrogen dioxide is linked to increased dementia risk, according to a major new meta-analysis involving over 24 million people.

A long-term study finds sotatercept continues to improve outcomes in patients with pulmonary arterial hypertension, with manageable safety risks.

A mobile asthma self-management tool improved symptoms in adults with uncontrolled asthma, but its effectiveness varied across racial groups.

Scientists uncover shared genetic signals between chronic dry cough and ACE inhibitor-induced cough, pointing to neurological pathways as potential targets.

Tozorakimab shows potential benefit in patients with COPD with frequent exacerbations, despite primary endpoint not being met in overall population.

Macrophages in COPD lungs show elevated carbon loads, larger cell size, and enhanced inflammation, highlighting a potential driver of disease progression.

Paediatric-onset bronchiectasis leads to more severe disease than adult-onset, highlighting need for early, tailored care.

MiDAS, a new clinical tool, predicts poor outcomes in difficult asthma by scoring multimorbidity burden, highlighting the need for whole-patient care.

A post hoc analysis confirms dupilumab reduces key inflammatory biomarkers and COPD exacerbations, with highest benefit in patients with raised eosinophils and FeNO.

A major European study finds that exposure to multiple urban environmental factors, including air pollution and lack of green space, is significantly linked to asthma risk from childhood to adulthood.

A 14-gene test helps identify patients with early-stage non-small-cell lung cancer who benefit from chemotherapy, significantly improving 24-month disease-free survival.

The serotonin receptor gene HTR1F was linked to increased risk of sleep apnoea in non-obese adults.

CHEST guideline updates support minimally invasive resection and targeted therapy to enhance survival in Stage I–II NSCLC.

Dupilumab was associated with increased lymphoma risk but lower overall mortality in a large asthma cohort study.

A new international trial has investigated the safety and efficacy of tailoring antibiotic treatment for cystic fibrosis exacerbations based on sputum microbiome analysis.

A genome-wide association study reveals four novel loci linked to primary spontaneous pneumothorax, identifying CBX7-mediated matrix dysregulation as a key pathogenic mechanism.

Air pollution and poverty accelerate ageing and worsen survival in fibrotic lung disease patients, new international epigenetic study reveals.

New global registry study reveals stark regional differences in diagnosis, treatment, and care quality for children with bronchiectasis.

New research links TP53, BRCA2, and ALKBH2 mutations to early-onset lung cancer in Asian women who have never smoked.

Early evidence shows that nirsevimab substantially reduced emergency bronchiolitis cases and hospital admissions in infants under 6 months.

A large Phase III trial has found that onradivir, a novel PB2 polymerase inhibitor, significantly shortens recovery time in adults with uncomplicated influenza A.

A structured parenting programme based on acceptance and commitment therapy has shown clinical benefits in managing asthma and ADHD symptoms in children.

New findings support the integration of PET/CT prior to biopsy in patients with intermediate-to-high-risk lung nodules.

A major international trial has assessed whether nasal high-flow oxygen improves outcomes during emergency paediatric intubation.

Next-generation metagenomic sequencing has uncovered key differences in bronchiectasis pathogens and resistance genes across Europe.

Machine learning models using data from digital inhalers can successfully predict COPD exacerbations up to 5 days in advance.

New research suggests that early impairment in mucosal IgA immunity may contribute to the later development of bronchiolitis obliterans syndrome in lung transplant recipients.

Gait parameters in people with COPD progressively worsen with disease severity and differ significantly from healthy older adults.

New research shows lung function peaks earlier in life and declines steadily without plateau, challenging prior assumptions.

A once-daily oral therapy targeting neutrophilic inflammation has shown promise in reducing exacerbations in patients with bronchiectasis.

Including imaging and symptom-based data in COPD diagnosis captures patients with high-risk disease who would otherwise be overlooked by spirometry alone.

Repeated exposure to antibiotics during the perinatal period in very low birth weight preterm infants is associated with impaired lung function by early school age.

A new study identifies airway eosinophilia as a distinct, corticosteroid-responsive subtype of COPD, marked by heightened type 2 inflammation and gene expression changes.

A new Phase III trial has strengthened the evidence supporting cytisinicline as an effective and well-tolerated medication for smoking cessation.

Rare genetic variants and common polygenic risk scores independently influence survival in idiopathic pulmonary fibrosis.

Discover how HSK31858 could transform bronchiectasis treatment by reducing flare-ups – read more about the latest trial results.

New data reveal that acute pulmonary embolism, though rare in children and adolescents, carries a significant risk of death.

Smoking may reduce the risk of developing ulcerative colitis and alleviate disease severity in existing cases.

Statistical analysis shows combined breathing and stretching exercises significantly improve respiratory function and exercise capacity in COPD patients.

Youth using varenicline with brief behavioral support were far more likely to quit vaping than those given placebo or usual care, a new randomized trial finds.

A new study supports the clinical utility of human nasal epithelial cultures as predictive biomarkers for cystic fibrosis CFTR modulator therapy.

Blood eosinophil count and fractional exhaled nitric oxide significantly enhance prognostic assessment of asthma attack risk.

A single dose of the RSVPreF3 OA vaccine offers strong protection against RSV-related lower respiratory tract disease in older adults across three seasons.

Explore how vaping during pregnancy affects maternal health and birth outcomes.

A new 96-week study confirms the long-term safety and sustained efficacy of elexacaftor/tezacaftor/ivacaftor in children with cystic fibrosis aged 6–11 years.

Inpatient pulmonary rehabilitation significantly enhances functional independence in patients with chronic lung disease and extends survival.

A study analysing trends in mortality from occupational chronic respiratory diseases caused by industrial pollutants highlights both progress and ongoing challenges.

Early exposure to ambient ozone in the first 2 years of life is associated with an increased risk of asthma and wheeze in early childhood.

A novel therapeutic vaccine, PRGN-2012, has shown promising results in treating recurrent respiratory papillomatosis.

Obstructive sleep apnoea may increase the risk of developing Parkinson’s, but early treatment with continuous positive airway pressure therapy mitigates this risk.

IL-33 inhibition with tozorakimab may offer clinical benefits in patients with COPD at high risk of exacerbations.

Young adults who use e-cigarettes may experience changes in lung ventilation distribution, potentially indicating early small airway impairment.

Children with above-average BMI trajectories are at increased risk of developing chronic obstructive pulmonary disease later in life.

Molecular residual disease detection may help identify patients with EGFR-mutated NSCLC who could benefit from prolonged adjuvant osimertinib

A new study highlights the significant impact of time of day and season on bronchodilator responsiveness.

A multicentre cohort study found that adherence to annual lung cancer screening declines over time, with lower adherence linked to reduced lung cancer detection rates.

New data confirm that positive airway pressure therapy is associated with a significant reduction in all-cause and cardiovascular mortality in patients with obstructive sleep apnoea.

New research finds that SGLT-2is and GLP-1RAs are associated with a lower risk of COPD exacerbations in patients with Type 2 diabetes and active COPD.

New research has identified a potential causal relationship between lipid metabolism and chronic obstructive pulmonary disease.

Adjuvant corticosteroid therapy reduces 30-day mortality in hospitalised patients with community-acquired pneumonia, but its benefits depend on baseline inflammation levels.

Gut microbiota composition may influence the efficacy and safety of chemo-immunotherapy in advanced non-small cell lung cancer.

A Phase IV trial has demonstrated that dupilumab significantly reduces airway inflammation in patients with uncontrolled, moderate-to-severe type 2 asthma.

Interim findings from the ongoing SOTERIA study suggest that sotatercept provides a favourable long-term safety and efficacy profile for adults with pulmonary arterial hypertension.

A new study assessed asthma risk in children who received antibiotics in the first week of life solely due to maternal indications, eliminating infection-related bias.

A large-scale study suggests that pirfenidone use in patients with idiopathic pulmonary fibrosis may be linked to a lower incidence of lung cancer.

Individuals with impaired lung function trajectories experience a higher burden of respiratory symptoms, including wheeze and phlegm.

The UK IPF Registry has provided new insights into the evolving landscape of idiopathic pulmonary fibrosis management, showing significant shifts in diagnosis and treatment approaches over the last decade.

Lung cancer screening presents a crucial opportunity to address tobacco dependence, as participation is associated with increased motivation to quit smoking.

A nationwide study from South Korea has found a concerning link between obstructive sleep apnea and suicidal behaviors.

Adding genetic risk scores to traditional case-finding methods enhances the detection of undiagnosed COPD, improving early diagnosis and intervention.

A large, multicentre study has demonstrated that robotic-assisted bronchoscopy is both safe and effective for diagnosing small and peripheral lung lesions.

A Phase III trial has shown that rezivertinib offers superior progression-free survival compared to gefitinib as a first-line treatment in EGFR-mutated locally advanced or metastatic non-small-cell lung cancer.

Adults who began smoking before the age of 15 have a significantly higher risk of COPD than those who started later, even when adjusting for smoking history and second-hand smoke exposure.

Extreme temperatures significantly increase morbidity and mortality risks for patients with chronic obstructive pulmonary disease.

A new study across five European countries highlights the impact of RSV on clinical outcomes, healthcare utilisation, and family life.

A large-scale study has revealed a significant association between long-term air pollution exposure and hospital admissions for acute lower respiratory infections in adults.

A new global analysis of lung cancer incidence has uncovered significant geographical and temporal variations in histological subtypes.

New research suggests that elevated circulating cAMP levels could serve as a potential biomarker for asthma.

Vitamin D deficiency is strongly associated with an increased risk of severe acute exacerbations in patients with chronic obstructive pulmonary disease.

New research reveals shifting patterns in lung cancer mortality, with declining smoking rates offset by rising deaths linked to air pollution.

A new qualitative study conducted in France highlights the multiple obstacles patients face before receiving a chronic obstructive pulmonary disease diagnosis.

A systematic review of 33 randomised controlled trials has found that conventional treatments for allergic rhinitis may also improve asthma outcomes in patients with both conditions.

A recent study has uncovered a new connection between genetic risk factors for idiopathic pulmonary fibrosis and the development of post-COVID-19 lung abnormalities.

Xpert MTB/RIF Ultra is able to enhance tuberculosis diagnosis and stratify transmission risk, offering a powerful tool for clinicians.

With traditional bronchial provocation tests often inaccessible in clinical settings, this predictive nomogram offers a practical alternative to assist clinicians.

The Prospector calculator reduces antibiotic use by nearly half in COPD exacerbations, showing promise for safer and more effective patient care.

A high blood NMLR is linked to increased 5-year mortality in COPD patients, highlighting its role as a key prognostic tool.

Home high-flow therapy improves recovery for COPD patients after severe exacerbations, showing potential for better symptom control and reduced readmissions.

A recent outbreak in India identified new hMPV strains, A2.2.1 and A2.2.2, highlighting the evolving threat of paediatric respiratory infections.

Combined valve implantation in the right upper and middle lobes shows promise for severe emphysema, with significant benefits for heterogeneous cases.

1 in 28 people globally will develop lung cancer, with men and wealthy nations at greatest risk, highlighting urgent healthcare disparities.

Changes in muscle-to-fat ratio affect lung function and airflow obstruction, highlighting the importance of body composition in respiratory health.

Rising blood eosinophil counts and high sputum IL-8 levels predict accelerated lung function decline in asthma, highlighting key biomarkers for monitoring.

LCI detects lung function improvements in cystic fibrosis patients on ETI therapy, even when FEV1 changes are minimal, highlighting its clinical value.

Lung cancer deaths among CLRD patients have declined, but older adults, rural areas, and White men remain disproportionately affected.

GLI spirometry criteria reduce COPD misclassification in older smokers, ensuring accurate diagnosis and preventing unnecessary treatments.

New research highlights the predictive power of gut microbiome profiles during acute COVID-19 infection in identifying individuals at risk for Long COVID.

A UK Biobank study links low birth weight to a 21% higher risk of developing COPD later in life. Findings highlight the importance of prenatal care and maternal health in reducing long-term respiratory risks.

A study reveals a strong link between primary ciliary dyskinesia and asthma in children.

Prenatal exposure to common phenols, including butylparaben, has been linked to an increased risk of asthma in children, particularly among boys, according to a large-scale study from Japan.

Living in disadvantaged neighbourhoods worsens lung function and raises mortality risk for idiopathic pulmonary fibrosis patients, especially those with milder disease, according to a new study.

New research highlights how patient-reported asthma symptoms can reveal underlying disease mechanisms, paving the way for personalised treatments.

Doctors should monitor thoracic trauma patients with lateral or posterior rib fractures, displacement, or multiple fractures closely for haemothorax risk, a study recommends.

New insights from a large-scale study reveal how humidity influences respiratory health, offering both protective benefits and potential risks to lung function.

Alcohol’s role in TB risk among diabetics: Moderate drinking may reduce risk, but heavy consumption sharply increases it, particularly for smokers.

Young adults with metabolic syndrome face a significantly increased risk of COPD development, emphasizing the importance of early monitoring and prevention.

Acute exacerbations significantly worsen survival in progressive pulmonary fibrosis, urging a need for targeted management strategies.

Asthma increases the risk of bronchiectasis, with sinusitis and eosinophilic inflammation acting as mediators, according to a new genetic study.